{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:50:24Z","timestamp":1791643824017,"version":"4.3.4"},"reference-count":195,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01752","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T04:22:00Z","timestamp":1512706920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid"],"prefix":"10.3389","volume":"8","author":[{"given":"Yale","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamadermatol.2013.112","article-title":"Bullous pemphigoid","volume":"149","author":"Rosenbach","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14419","article-title":"Bullous pemphigoid associated with silicosis","author":"Zhu","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B4","first-page":"214","article-title":"PUVA-induced bullous pemphigoid in psoriasis","volume":"24","author":"Caca-Biljanovska","year":"2016","journal-title":"Acta Dermatovenerologica Croatica"},{"key":"B5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.autrev.2011.04.003","article-title":"Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature","volume":"10","author":"Sagi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/ther.2013.0013","article-title":"Bullous lesions after use of a commercial therapeutic hypothermia temperature management system: a possible burn injury?","volume":"3","author":"Wang","year":"2013","journal-title":"Ther Hypothermia Temp Manag"},{"key":"B7","first-page":"219","article-title":"Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies","volume":"97","author":"Shon","year":"2016","journal-title":"Cutis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13410-014-0212-0","article-title":"Electrical stimulation-induced bullous formation in a pemphigoid diabetic patient: a case report","volume":"35","author":"Annabestani","year":"2015","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jaad.2016.05.025","article-title":"The proteolytic effect of bromelain on bullous pemphigoid antigen-2","volume":"75","author":"Belcher","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11606-016-3679-1","article-title":"Drug-induced bullous pemphigoid","volume":"31","author":"Kanahara","year":"2016","journal-title":"J Gen Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/bjd.15111","article-title":"Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180","volume":"176","author":"Sakai","year":"2017","journal-title":"Br J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/mop.0000000000000381","article-title":"Blistering diseases in neonates","volume":"28","author":"Zhao","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/bjd.14822","article-title":"Complement in bullous pemphigoid: results from a large observational study","volume":"176","author":"Romeijn","year":"2017","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"Sardy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1346-8138.13207","article-title":"Bullous pemphigoid: what\u2019s ahead?","volume":"43","author":"Furue","year":"2016","journal-title":"J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2017.06.005","article-title":"BPAG1, a distinctive role in skin and neurological diseases","volume":"69","author":"Ali","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.jaad.2013.06.006","article-title":"A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180","volume":"70","author":"Osawa","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2011","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","article-title":"Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience","volume":"308","author":"Keller","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/ijd.12243","article-title":"Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study","volume":"54","author":"Barrick","year":"2015","journal-title":"Int J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis","volume":"77","author":"Atzmony","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis","volume":"30","author":"Lai","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1160\/th15-04-0309","article-title":"Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study","volume":"115","author":"Cugno","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00403-017-1736-1","article-title":"Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis","volume":"309","author":"Liu","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archdermatol.2012.2994","article-title":"Mortality of bullous pemphigoid in China","volume":"149","author":"Li","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2011.04391.x","article-title":"Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases","volume":"165","author":"Marzano","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","article-title":"Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications","volume":"160","author":"Marzano","year":"2009","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/s0140-6736(17)30549-4","article-title":"Doxycycline: a first-line treatment for bullous pemphigoid?","volume":"389","author":"Grantham","year":"2017","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/s0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaad.2015.11.030","article-title":"Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: a retrospective study with a 6-year follow-up","volume":"74","author":"Ahmed","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B40","first-page":"264","article-title":"Bullous pemphigoid treated with intravenous immunoglobulin","volume":"93","author":"Tuchinda","year":"2014","journal-title":"Cutis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri3401-c1","article-title":"IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist","volume":"14","author":"von Gunten","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.clindermatol.2013.01.007","article-title":"Bullous pemphigoid: associations and management guidelines: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cei.12566","article-title":"T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid","volume":"180","author":"Pickford","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2340\/00015555-2101","article-title":"Enzyme-linked immunoassay index for anti-NC16a IgG and IgE auto-antibodies correlates with severity and activity of bullous pemphigoid","volume":"96","author":"Kalowska","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.4238\/2014.March.17.7","article-title":"Whole exome sequencing implicates PTCH1 and COL17A1 genes in ossification of the posterior longitudinal ligament of the cervical spine in Chinese patients","volume":"13","author":"Wei","year":"2014","journal-title":"Genet Mol Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00441-015-2216-6","article-title":"Molecular architecture and function of the hemidesmosome","volume":"360","author":"Walko","year":"2015","journal-title":"Cell Tissue Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"29940","DOI":"10.1074\/jbc.M112.345454","article-title":"Coiled coils ensure the physiological ectodomain shedding of collagen XVII","volume":"287","author":"Nishie","year":"2012","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horvath","year":"2010","journal-title":"Exp Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1067\/mjd.2000.103986","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2133.2008.08858.x","article-title":"IgE autoantibodies against the intracellular domain of BP180","volume":"160","author":"Dresow","year":"2009","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1346-8138.2012.01562.x","article-title":"Unilateral bullous pemphigoid without erythema and eosinophil infiltration in a hemiplegic patient","volume":"39","author":"Tsuruta","year":"2012","journal-title":"J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archdermatol.2009.331","article-title":"Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects","volume":"146","author":"Wieland","year":"2010","journal-title":"Arch Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0165-2478(01)00212-7","article-title":"Characterization of BALB\/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid","volume":"77","author":"Xu","year":"2001","journal-title":"Immunol Lett"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.4049\/jimmunol.1402771","article-title":"Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera","volume":"194","author":"Madi","year":"2015","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrrheum.2013.184","article-title":"Autoantibodies and SLE: the threshold for disease","volume":"10","author":"Olsen","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1126\/science.aaa7017","article-title":"Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance","volume":"348","author":"Yang","year":"2015","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/ni.3331","article-title":"CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors","volume":"17","author":"Kalekar","year":"2016","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer\u2019s disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jdv.12091","article-title":"Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid","volume":"28","author":"Antiga","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/ijd.12967","article-title":"The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid","volume":"54","author":"Rychlik-Sych","year":"2015","journal-title":"Int J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC Class II genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00403-012-1213-9","article-title":"Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients","volume":"304","author":"Quaglino","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/exd.12421","article-title":"B-cell activating factor detected on both naive and memory B cells in bullous pemphigoid","volume":"23","author":"Qian","year":"2014","journal-title":"Exp Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2006.12.008","article-title":"Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid","volume":"46","author":"Watanabe","year":"2007","journal-title":"J Dermatol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clim.2011.12.003","article-title":"Blistering insights into the pathogenesis of bullous pemphigoid","volume":"142","author":"Wong","year":"2012","journal-title":"Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.clim.2011.10.002","article-title":"Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","volume":"142","author":"Ujiie","year":"2012","journal-title":"Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamadermatol.2013.5757","article-title":"Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study","volume":"150","author":"Fichel","year":"2014","journal-title":"JAMA Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B80","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.autrev.2015.04.008","article-title":"Revisiting the role of mast cells in autoimmunity","volume":"14","author":"Yu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1172\/jci17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41598-017-00235-3","article-title":"Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid","volume":"7","author":"Qiao","year":"2017","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen","volume":"176","author":"Wang","year":"2010","journal-title":"Am J Pathol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","article-title":"Fcgamma receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid","volume":"184","author":"Schulze","year":"2014","journal-title":"Am J Pathol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/exd.12146","article-title":"Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida","volume":"22","author":"Iwata","year":"2013","journal-title":"Exp Dermatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/labinvest.2016.108","article-title":"Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C","volume":"96","author":"Iwata","year":"2016","journal-title":"Lab Invest"},{"key":"B89","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jdv.12929","article-title":"Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid","volume":"30","author":"Tukaj","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1600-0625.2012.01529.x","article-title":"Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8","volume":"21","author":"Van den Bergh","year":"2012","journal-title":"Exp Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjd.14411","article-title":"Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1346-8138.13051","article-title":"Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis","volume":"43","author":"Zhou","year":"2016","journal-title":"J Dermatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid","volume":"73","author":"Zuo","year":"2016","journal-title":"J Autoimmun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00403-015-1598-3","article-title":"Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid","volume":"307","author":"Bing","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdermsci.2016.03.009","article-title":"High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoid","volume":"83","author":"Cho","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2015.02.009","article-title":"Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid","volume":"78","author":"Kamiya","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br J Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamadermatol.2017.0091","article-title":"Rituximab treatment of nivolumab-induced bullous pemphigoid","volume":"153","author":"Sowerby","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.12883","article-title":"Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid","volume":"25","author":"Messingham","year":"2016","journal-title":"Exp Dermatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, FcepsilonRI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS One"},{"key":"B107","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/1744666x.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/jdv.13758","article-title":"Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature","volume":"30","author":"Balakirski","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12026-014-8547-7","article-title":"Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid","volume":"59","author":"Messingham","year":"2014","journal-title":"Immunol Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/hyb.2011.0102","article-title":"Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180","volume":"2012","author":"Messingham","year":"2005","journal-title":"Hybridoma"},{"key":"B114","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/bjd.14351","article-title":"Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid","volume":"174","author":"Ali","year":"2016","journal-title":"Br J Dermatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/bjd.13113","article-title":"A case of oral mucous membrane pemphigoid with IgG antibodies to integrin alpha6beta4","volume":"171","author":"Miyamoto","year":"2014","journal-title":"Br J Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1684\/ejd.2014.2322","article-title":"Bullous pemphigoid with IgG anti-LAD-1 antibodies","volume":"24","author":"Matsui","year":"2014","journal-title":"Eur J Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","article-title":"IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis","volume":"143","author":"Christophoridis","year":"2000","journal-title":"Br J Dermatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-4632.2007.03317.x","article-title":"A case of linear IgA disease in a child with IgA and IgG circulating antibodies directed to BPAg2","volume":"46","author":"Viglizzo","year":"2007","journal-title":"Int J Dermatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","article-title":"IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180","volume":"112","author":"Perriard","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1046\/j.1365-2133.2001.04130.x","article-title":"Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses","volume":"144","author":"Laffitte","year":"2001","journal-title":"Br J Dermatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/jaut.1996.0038","article-title":"The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and\/or cell damage","volume":"9","author":"Alarcon-Segovia","year":"1996","journal-title":"J Autoimmun"},{"key":"B125","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/bjd.15195","article-title":"The association between drugs and bullous pemphigoid","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/jid.2014.443","article-title":"Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice","volume":"135","author":"Hurskainen","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.5070\/D32110028946","article-title":"IgM ocular cicatricial pemphigoid: a unique insight into the immune system","volume":"21","author":"Tazudeen","year":"2015","journal-title":"Dermatol Online J"},{"key":"B133","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/bjd.14692","article-title":"Summary of results of serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University","volume":"175","author":"Hashimoto","year":"2016","journal-title":"Br J Dermatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/bjd.14686","article-title":"Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid","volume":"175","author":"Glauser","year":"2016","journal-title":"Br J Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1590\/abd1806-4841.20143221","article-title":"Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience","volume":"89","author":"Arbache","year":"2014","journal-title":"An Bras Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/1346-8138.13170","article-title":"Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia","volume":"43","author":"Maki","year":"2016","journal-title":"J Dermatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12887-017-0813-0","article-title":"Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger","volume":"17","author":"Baroero","year":"2017","journal-title":"BMC Pediatr"},{"key":"B138","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/ced.12166","article-title":"Immunobullous dermatosis associated with Waldenstrom macroglobulinaemia treated with rituximab","volume":"38","author":"Chattopadhyay","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1046\/j.1365-2133.2001.04427.x","article-title":"Bullous pemphigoid arising in surgical wounds","volume":"145","author":"Anderson","year":"2001","journal-title":"Br J Dermatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1093\/emboj\/cdf532","article-title":"Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs","volume":"21","author":"Franzke","year":"2002","journal-title":"EMBO J"},{"key":"B141","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1365-2230.2005.01937.x","article-title":"Collagen XVII\/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex","volume":"30","author":"Powell","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jid.2016.01.012","article-title":"Collagen XVII shedding suppresses re-epithelialization by directing keratinocyte migration and dampening mTOR signaling","volume":"136","author":"Jackow","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jid.2015.10.060","article-title":"Generation of a functional non-shedding collagen XVII mouse model: relevance of collagen XVII shedding in wound healing","volume":"136","author":"Jackow","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.01.012","article-title":"Context-dependent regulation of collagen XVII ectodomain shedding in skin","volume":"185","author":"Nishie","year":"2015","journal-title":"Am J Pathol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/bjd.15113","article-title":"Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid","volume":"176","author":"Kabuto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13382","article-title":"Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid","author":"Bieber","year":"2017","journal-title":"Exp Dermatol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"967987","DOI":"10.1155\/2013\/967987","article-title":"IL-17 expression in dermatitis herpetiformis and bullous pemphigoid","volume":"2013","author":"Zebrowska","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B148","doi-asserted-by":"publisher","first-page":"8980534","DOI":"10.1155\/2017\/8980534","article-title":"Correlation between IL36alpha and IL17 and activity of the disease in selected autoimmune blistering diseases","volume":"2017","author":"Zebrowska","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/jdv.12719","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) levels reflect the disease activity in a patient with bullous pemphigoid","volume":"30","author":"Nin-Asai","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/jid.2011.251","article-title":"High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid","volume":"132","author":"Kagami","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2340\/00015555-2581","article-title":"Increased activity and apoptosis of eosinophils in blister fluids, skin and peripheral blood of patients with bullous pemphigoid","volume":"97","author":"Engmann","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2016.08.012","article-title":"Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes","volume":"139","author":"Riani","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.it.2017.04.001","article-title":"Rheostatic functions of mast cells in the control of innate and adaptive immune responses","volume":"138","author":"Frossi","year":"2017","journal-title":"Trends Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04464.x","article-title":"Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid","volume":"166","author":"Gunther","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B157","doi-asserted-by":"publisher","first-page":"246126","DOI":"10.1155\/2015\/246126","article-title":"Mast cell and autoimmune diseases","volume":"2015","author":"Xu","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B158","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000365946","article-title":"Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid","volume":"229","author":"Furudate","year":"2014","journal-title":"Dermatology"},{"key":"B159","doi-asserted-by":"publisher","first-page":"e0117497","DOI":"10.1371\/journal.pone.0117497","article-title":"Therapy with plasma purified alpha1-antitrypsin (Prolastin(R)) induces time-dependent changes in plasma levels of MMP-9 and MPO","volume":"10","author":"Koepke","year":"2015","journal-title":"PLoS One"},{"key":"B160","doi-asserted-by":"publisher","first-page":"37358","DOI":"10.1074\/jbc.M111.272401","article-title":"Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid","volume":"286","author":"Lin","year":"2011","journal-title":"J Biol Chem"},{"key":"B161","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13416","article-title":"Eosinophils as putative therapeutic targets in bullous pemphigoid","author":"Simon","year":"2017","journal-title":"Exp Dermatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.12464","article-title":"Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid","volume":"29","author":"Tedeschi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"217ra1","DOI":"10.1126\/scitranslmed.3007116","article-title":"The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity","volume":"6","author":"Bergin","year":"2014","journal-title":"Sci Transl Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/srep18001","article-title":"Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome","volume":"5","author":"Plee","year":"2015","journal-title":"Sci Rep"},{"key":"B167","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2","volume":"15","author":"Taylor","year":"2014","journal-title":"Nat Immunol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"6746870","DOI":"10.1155\/2017\/6746870","article-title":"TWEAK\/Fn14 activation participates in skin inflammation","volume":"2017","author":"Liu","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B169","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2017.00651","article-title":"TWEAK\/Fn14 activation participates in Ro52-mediated photosensitization in cutaneous lupus erythematosus","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1600-0560.2011.01762.x","article-title":"Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes","volume":"38","author":"Peternel","year":"2011","journal-title":"J Cutan Pathol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/10641955.2015.1032054","article-title":"IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia","volume":"34","author":"Harmon","year":"2015","journal-title":"Hypertens Pregnancy"},{"key":"B172","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cyto.2015.11.020","article-title":"Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cells","volume":"78","author":"Kim","year":"2016","journal-title":"Cytokine"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2016-09-741629","article-title":"PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy","volume":"129","author":"Asano","year":"2017","journal-title":"Blood"},{"key":"B174","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.3892\/mmr.2017.6484","article-title":"Antiinflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17\u2009cells","volume":"15","author":"Ma","year":"2017","journal-title":"Mol Med Rep"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/jid.2012.19","article-title":"Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance","volume":"132","author":"Ettinger","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"B177","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2013.11.014","article-title":"Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)","volume":"74","author":"Ronaghy","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ced.13092","article-title":"Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin","volume":"42","author":"Nguyen","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/cei.12604","article-title":"Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells","volume":"180","author":"De Bruyne","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/bjh.14770","article-title":"The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer","volume":"179","author":"Flynn","year":"2017","journal-title":"Br J Haematol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrrheum.2015.106","article-title":"Pathogenesis and targeted treatment of skin injury in SLE","volume":"11","author":"Deng","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/annrheumdis-2012-202775","article-title":"Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B183","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2174\/156652413805076867","article-title":"In vitro and in vivo evaluation of a humanized anti-APRIL antibody","volume":"13","author":"Gao","year":"2013","journal-title":"Curr Mol Med"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e0137044","DOI":"10.1371\/journal.pone.0137044","article-title":"Pathogenic role of a proliferation-inducing ligand (APRIL) in murine IgA nephropathy","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"B185","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1158\/1538-7445.AM2016-5004","article-title":"A humanized anti-CD40 antibody with strong immune-modulatory activities capable of tumor eradication","volume":"76","author":"Bj\u00f6rck","year":"2016","journal-title":"Cancer Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10875-016-0272-7","article-title":"The Fc\u03b3R\/IgG interaction as target for the treatment of autoimmune diseases","volume":"36","author":"Sondermann","year":"2016","journal-title":"J Clin Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"e103568","DOI":"10.1371\/journal.pone.0103568","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption","volume":"9","author":"Biesenbach","year":"2014","journal-title":"PLoS One"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jaad.2014.06.014","article-title":"Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series","volume":"71","author":"Kasperkiewicz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14579","article-title":"Three new cases of bullous pemphigoid during anti-PD-1 antibody therapy","author":"Le Naour","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/imm.12609","article-title":"Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis","volume":"148","author":"Huss","year":"2016","journal-title":"Immunology"},{"key":"B192","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/TP.0b013e31826d4672","article-title":"Costimulation blockade: current perspectives and implications for therapy","volume":"95","author":"Kinnear","year":"2013","journal-title":"Transplantation"},{"key":"B193","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2014.125","article-title":"Role and therapeutic value of dendritic cells in central nervous system autoimmunity","volume":"22","author":"Quintana","year":"2015","journal-title":"Cell Death Differ"},{"key":"B194","doi-asserted-by":"publisher","first-page":"857143","DOI":"10.1155\/2014\/857143","article-title":"The role of dendritic cells in tissue-specific autoimmunity","volume":"2014","author":"Mbongue","year":"2014","journal-title":"J Immunol Res"},{"key":"B195","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s10067-016-3354-2","article-title":"Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus","volume":"35","author":"Huang","year":"2016","journal-title":"Clin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:28:01Z","timestamp":1693337281000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":195,"alternative-id":["10.3389\/fimmu.2017.01752"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01752","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]},"article-number":"1752"}}